Neuro-Oncology Reviews

Volume 24 Number 21
15 November 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 21, 15 November

Fu X, Shi D, Feng Y.
The Efficacy and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent Glioblastoma: A Meta-analysis of Randomized Controlled Studies.
Clin Neuropharmacol. 2022 Nov-Dec;45(6):162-167→. doi: 10.1097/WNF.0000000000000525→. PMID: 36383914→. Meta-analysis˰ ˍ

Tariq R, Saeed Baqai MW, Shamim MS.
Quality of Life in Paediatric Survivors of Medulloblastoma.
J Pak Med Assoc. 2022 Nov;72(11):2339-2340→. doi: 10.47391/JPMA.22-111?. PMID: 37013321→. Review. ˍ

Fu DB, Kong XT, Veenema TG, Bota DA, Koirala B.
Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study.
J Adv Pract Oncol. 2022 Nov 1;13(8):775-789→. doi: 10.6004/jadpro.2022.13.8.4→. PMID: 36727021→. Guidelines. ˍ

Hosseinalizadeh H, Mahmoodpour M, Razaghi Bahabadi Z, Hamblin MR, Mirzaei H.
Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review.
Biomed Pharmacother. 2022 Nov 1;156:113841→. doi: 10.1016/j.biopha.2022.113841→. PMID: 36411657→. Review. ˍ

Onishi S, Ohba S, Kuraoka K, Kurashige T, Sugiyama K, Yamasaki F.
Molecular and clinical characterization of H3 K27M-mutant "non-midline" glioblastoma: A case report and literature review.
Neurocirugia (Astur:Engl Ed). 2022 Nov 1;33(6):356-360→. doi: 10.1016/j.neucie.2021.06.008→. PMID: 36333093→. Case report, Review˰ ˍ

Wu L, Chai R, Zhao Z, Wang Q, Jiang T.
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies.
Cancer Biol Med. 2022 Nov 1;19(10):1423–7→. doi: 10.20892/j.issn.2095-3941.2022.0363→. PMID: 36350003→. Editorial. ˍ

Haddad AF, Aghi MK, Butowski N.
Novel intraoperative strategies for enhancing tumor control: Future directions.
Neuro Oncol. 2022 Nov 2;24(S6):S25-S32→. doi: 10.1093/neuonc/noac090→. PMID: 36322096→. Review. ˍ

Odia Y, Gutierrez AN, Kotecha R.
Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review. [GammaTile®]
Neuro Oncol. 2022 Nov 2;24(S6):S16-S24→. doi: 10.1093/neuonc/noac130→. PMID: 36322100→. Review. ˍ

Schupper AJ, Chanenchuk T, Racanelli A, Price G, Hadjipanayis CG.
Laser hyperthermia: Past, present, and future. [LITT]
Neuro Oncol. 2022 Nov 2;24(S6):S42-S51→. doi: 10.1093/neuonc/noac208→. PMID: 36322099→. Review. ˍ

Wu A, Wu JY, Lim M.
Updates in intraoperative strategies for enhancing intra-axial brain tumor control.
Neuro Oncol. 2022 Nov 2;24(S6):S33-S41→. doi: 10.1093/neuonc/noac170→. PMID: 36322098→. Review. ˍ

Bahadur S, Prakash A.
A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.
Curr Drug Targets. 2022 Nov 3→. doi: 10.2174/1389450124666221019141044→. PMID: 36278468→. Review˰ ˍ

Khristov V, Lin A, Freedman Z, Staub J, Shenoy G, Mrowczynski O, Rizk E, Zacharia B, Connor J.
Tumor-derived Biomarkers in Liquid Biopsy of Glioblastoma.
World Neurosurg. 2022 Nov 5:S1878-8750(22)01554-6→. doi: 10.1016/j.wneu.2022.11.012→. PMID: 36347463→. Review˰ ˍ

Mehrdadi S.
Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Adv Pharm Bull. 2022 Nov 5;13(3):512-520∟. doi: 10.34172/apb.2023.062∟. PMID: 37646057∟. Review. ˍ

Seliger C, Oppong FB, Lefranc F, Chinot O, Stupp R, Nabors B, Gorlia T, Weller M; EORTC Brain Tumor Group.
Research Article: Association of antidepressant drug use with outcome of patients with glioblastoma.
Int J Cancer. 2022 Nov 8→. doi: 10.1002/ijc.34344→. PMID: 36346112→. Pooled analysis. ˍ

Adnani L, Spinelli C, Tawil N, Rak J.
Role of extracellular vesicles in cancer-specific interactions between tumour cells and the vasculature.
Semin Cancer Biol. 2022 Nov 9:S1044-579X(22)00225-5→. doi: 10.1016/j.semcancer.2022.11.003→. PMID: 36371024→. Review˰ ˍ

Oztek MA, Noda SM, Romberg EK, Cole BL, Wright JN, Ishak GE, Perez FA.
Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
Pediatr Radiol. 2022 Nov 9→. doi: 10.1007/s00247-022-05546-w→. PMID: 36348014→. Review˰ ˍ

Chidley P, Shanker M, Phillips C, Haghighi N, Pinkham MB, Whittle JR, Sia J.
Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature.
J Neurooncol. 2022 Nov 10:1–14→. doi: 10.1007/s11060-022-04151-z→. PMID: 36355260→. Observational study, Meta-analysis. ˍ

*

Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan B.
Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis.
Front Oncol. 2022 Nov 10;12:1055366→. doi: 10.3389/fonc.2022.1055366→. PMID: 36439464→. Bibliometric analysis. ˍ
Supplementary materials→. ˍ ˍ

*

Li R, Huang Q, Ye C, Wu C, Luo N, Lu Y, Fang J, Wang Y.
Bibliometric and visual analysis in the field of ketogenic diet on cancer from 2012 to 2021.
Front Nutr. 2022 Nov 10;9:1060436→. doi: 10.3389/fnut.2022.1060436→. PMID: 36438725→. Bibliometric analysis. ˍ

Yang Y, Schubert MC, Kuner T, Wick W, Winkler F, Venkataramani V.
Brain Tumor Networks in Diffuse Glioma.
Neurotherapeutics. 2022 Nov 10→. doi: 10.1007/s13311-022-01320-w→. PMID: 36357661→. Review. ˍ

Brennan PM.
The future of brain tumor liquid biopsies in the clinic.
Neurooncol Adv. 2022 Nov 11;4(S2):ii4-ii5→. doi: 10.1093/noajnl/vdac091→. PMID: 36380870→. Opinion. ˍ

Kizilbash SH.
Why has targeting EGFR aberrations in glioblastoma therapy had limited success?
Expert Rev Anticancer Ther. 2022 Nov 11→. doi: 10.1080/14737140.2022.2146581→. PMID: 36367033→. Editorial. ˍ

Mathios D, Phallen J.
Advances in molecular biomarkers and liquid biopsy in gliomas.
Neurooncol Adv. 2022 Nov 11;4(S2):ii15-ii21→. doi: 10.1093/noajnl/vdac151→. PMID: 36380861→. Review. ˍ

Westphal M, Pantel K, Ricklefs FL, Maire C, Riethdorf S, Mohme M, Wikman H, Lamszus K.
Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations.
Neurooncol Adv. 2022 Nov 11;4(S2):ii45-ii52→. doi: 10.1093/noajnl/vdac015→. PMID: 36380859→. Review. ˍ

Luo J, Junaid M, Hamid N, Duan JJ, Yang X, Pei DS.
Current understanding of gliomagenesis: from model to mechanism.
Int J Med Sci. 2022 Nov 14;19(14):2071-2079→. doi: 10.7150/ijms.77287→. PMID: 36483593→. Review. ˍ

Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T.
Challenges in glioblastoma research: focus on the tumor microenvironment.
Trends Cancer. 2022 Nov 15:S2405-8033(22)00220-5→. doi: 10.1016/j.trecan.2022.09.005→. PMID: 36400694→. Review˰ ˍ

Luo Y, Zhang S, Tan W, Lin G, Zhuang Y, Zeng H.
The Diagnostic Efficiency of Quantitative Diffusion Weighted Imaging in Differentiating Medulloblastoma from Posterior Fossa Tumors: A Systematic Review and Meta-Analysis.
Diagnostics (Basel). 2022 Nov 15;12(11):2796→. doi: 10.3390/diagnostics12112796→. PMID: 36428860→. Review. ˍ

Rajabian A, Farzanehfar M, Hosseini H, Arab FL, Nikkhah A.
Boswellic acids as promising agents for the management of brain diseases.
Life Sci. 2022 Nov 15:121196→. doi: 10.1016/j.lfs.2022.121196→. PMID: 36400202→. Review˰ ˍ

*

Song P, Li H, Xu K, Li ZW, Ren X, Fu XJ.
A bibliometric and visualization-based analysis of temozolomide research hotspots and frontier evolution.
Front Oncol. 2022 Nov 15;12:905868→. doi: 10.3389/fonc.2022.905868→. PMID: 36457514→. Bibliometric analysis. ˍ

Yearley AG, Blitz SE, Patel RV, Chan A, Baird LC, Friedman GK, Arnaout O, Smith TR, Bernstock JD.
Machine Learning in the Classification of Pediatric Posterior Fossa Tumors: A Systematic Review.
Cancers (Basel). 2022 Nov 15;14(22):5608→. doi: 10.3390/cancers14225608→. PMID: 36428701→. Review. ˍ